Clinical Trial Update: Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness of zoledronic acid to prevent osteoporosis in early breast cancer patients receiving letrozole has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Letrozole (letrozole)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Soroka University Medical Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED